Krystal Biotech, Inc. (the "Company”) (NASDAQ: KRYS) today reported financial results for the first quarter ending March 31, 2026 and provided a business update. "Following a successful 2025, we are ...

Good morning, everyone, and thank you for joining Naturgy's First Quarter 2026 Results Presentation. This is Abel Arbat speaking from the Capital Markets team at Naturgy. Next to me sits the Global ...

This important cross-species study tests whether the corpus callosum contains parallel, segregated pathways for ipsilateral and contralateral visual-field information, rather than mixed inputs from ...

Joining us today is Panna Sharma, Chief Executive Officer, President and Director of Lantern Pharma, who will guide us through the demonstration and discuss the broader implications of this technology ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent® global net sales(recorded by Sanofi) increased 33% ...

India is experiencing an intense heatwave, possibly linked to a developing Super El Niño, raising concerns about heat-related ...

First quarter 2026 revenues increased 19% to $3.6 billion versus first quarter 2025Dupixent- global net sales (recorded by Sanofi) increased 33% to $4.9 billion EYLEA HD- U.S. net sales increased 52% ...

With the rapid expansion of the new energy vehicle (NEV) market, charging and battery swapping have emerged as the two ...

Expert printing guides, business marketing tips, and design tutorials from South Africa's leading online printing company.

II. The Chinese Side Has Scrupulously Honored the Phase One Economic and Trade Agreement III. The US Side Has Failed to Meet Its Obligations Under the Phase One Economic and Trade Agreement As the ...